Compare BTMD & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | CBAT |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 79.2M |
| IPO Year | N/A | N/A |
| Metric | BTMD | CBAT |
|---|---|---|
| Price | $2.45 | $0.86 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 124.9K | ★ 145.7K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 270.48 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $195,645,000.00 | $161,757,685.00 |
| Revenue This Year | N/A | $16.06 |
| Revenue Next Year | $2.80 | $70.59 |
| P/E Ratio | $3.34 | ★ N/A |
| Revenue Growth | ★ 1.34 | N/A |
| 52 Week Low | $2.32 | $0.57 |
| 52 Week High | $6.36 | $1.25 |
| Indicator | BTMD | CBAT |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 44.76 |
| Support Level | $2.56 | $0.83 |
| Resistance Level | $2.80 | $0.93 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 1.14 | 32.43 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.